These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30066305)

  • 1. Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson's Disease.
    Cruces-Sande A; Rodríguez-Pérez AI; Herbello-Hermelo P; Bermejo-Barrera P; Méndez-Álvarez E; Labandeira-García JL; Soto-Otero R
    Mol Neurobiol; 2019 Apr; 56(4):2845-2854. PubMed ID: 30066305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper increases the ability of 6-hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease.
    Cruces-Sande A; Méndez-Álvarez E; Soto-Otero R
    J Neurochem; 2017 Jun; 141(5):738-749. PubMed ID: 28294337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.
    Sánchez-Iglesias S; Méndez-Alvarez E; Iglesias-González J; Muñoz-Patiño A; Sánchez-Sellero I; Labandeira-García JL; Soto-Otero R
    J Neurochem; 2009 May; 109(3):879-88. PubMed ID: 19425176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease.
    Sánchez-Iglesias S; Rey P; Méndez-Alvarez E; Labandeira-García JL; Soto-Otero R
    Neurochem Res; 2007 Jan; 32(1):99-105. PubMed ID: 17160721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
    Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.
    Lopez-Real A; Rey P; Soto-Otero R; Mendez-Alvarez E; Labandeira-Garcia JL
    J Neurosci Res; 2005 Sep; 81(6):865-73. PubMed ID: 16015598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Zn
    Tamano H; Nishio R; Morioka H; Takeda A
    Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.
    Choi DH; Cristóvão AC; Guhathakurta S; Lee J; Joh TH; Beal MF; Kim YS
    Antioxid Redox Signal; 2012 May; 16(10):1033-45. PubMed ID: 22098189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.
    Méndez-Alvarez E; Soto-Otero R; Hermida-Ameijeiras A; López-Real AM; Labandeira-García JL
    Biochim Biophys Acta; 2002 Mar; 1586(2):155-68. PubMed ID: 11959457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.
    Rey P; Lopez-Real A; Sanchez-Iglesias S; Muñoz A; Soto-Otero R; Labandeira-Garcia JL
    Neurobiol Aging; 2007 Apr; 28(4):555-67. PubMed ID: 16621167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Absence of Gastrointestinal Redox Dyshomeostasis in the Brain-First Rat Model of Parkinson's Disease Induced by Bilateral Intrastriatal 6-Hydroxydopamine.
    Homolak J; Joja M; Grabaric G; Schiatti E; Virag D; Babic Perhoc A; Knezovic A; Osmanovic Barilar J; Salkovic-Petrisic M
    Mol Neurobiol; 2024 Aug; 61(8):5481-5493. PubMed ID: 38200352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
    Chen Y; Zhang DQ; Liao Z; Wang B; Gong S; Wang C; Zhang MZ; Wang GH; Cai H; Liao FF; Xu JP
    Mol Neurodegener; 2015 Mar; 10():4. PubMed ID: 26013581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.